Table 1.
Some clinical data in control and different tested groups
| Normal range | Control group | Diabetic Group | Cardiovascular diabetic group | |
|---|---|---|---|---|
| FBS (mg/dl) | 60-110 | 84.0 ± 8.9** | 268.6 ± 94.2** | 347.0 ± 66.9 |
| HbA1c (%) | < 6.5 | 4.9 ± 0.7** | 9.1 ± 2.0** | 10.3 ± 1.1 |
| TC (mg/dl) | < 200 | 105.8 ± 9.1** | 157.9 ± 28.9** | 262.7 ± 19.8 |
| TG (mg/dl) | 35-140 | 75.6 ± 8.7** | 123 ± 22.8** | 387.8 ± 71.9 |
| HDL-C (mg/dl) | >55 | 59.9 ± 4.6** | 52.9 ± 6.8** | 22.9 ± 4.7 |
| LDL-C (mg/dl) | < 150 | 30.6 ± 11.0** | 80.4 ± 30.1** | 162.2 ± 21.6 |
| LDL-C/HDL-C | < 2 | 0.5** | 1.6** | 7.4 |
| CK (U/L) | Up to 120 | 54.5 ± 10.2** | 42.5 ± 7.8** | 128.1 ± 23.7 |
| CK-MB (U/L) | 0-24 | 21.9 ± 3.9* | 18.5 ± 3.8** | 25.2 ± 3.7 |
| LDH (U/L) | 160-320 | 207.3 ± 12.5** | 214.6 ± 23.8** | 620.3 ± 101.9 |
Mean ± SD, vs. cardiovascular diabetic group.
*
P ≤ 0.05;
**
P ≤ 0.001.